Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells

Egr2 and 3 control inflammation, but maintain homeostasis, of PD-1high memory phenotype CD4 T cells
复制标题

Egr2和3控制炎症,但维持PD-1高记忆表型CD4 T细胞的稳态

DOI:
10.26508/lsa.202000766
复制
发表时间:
2020-09-01
影响因子:
4.4
通讯作者:
Wang, Ping
Wang, Ping
中科院分区:
生物学2区
文献类型:
--
作者:
Symonds, Alistair L. J.;Zheng, Wei;Wang, Ping

文献摘要

被引文献

相似文献

转录因子Egr 2和3对于控制记忆表型(MP)CD 4 T细胞的炎性自身免疫应答是必不可少的。然而,其机制尚不清楚。我们现在已经发现MP CD 4 T细胞的Egr 2(+)亚群(PD-1(高)MP)表达高水平的检查点分子(PD-1和Lag 3)以及效应T细胞的标志物(CXCR 3和ICAM-1)。Egr 2/3不是PD-1(高)MP CD 4细胞发育所必需的,但介导一种独特的转录程序,可有效控制其炎症反应,同时促进稳态增殖和适应性反应。Egr 2阴性PD-1(高)MP CD 4 T细胞在稳态增殖和针对病毒感染的适应性应答中受损,但对先天刺激(如IL-12)显示出炎症应答。PD-1(高)MP CD 4 T细胞最近被认为与类风湿性关节炎发病机制有关,我们现在发现,与健康对照相比,活动性类风湿性关节炎患者的PD-1(高)MP CD 4 T细胞中Egr 2表达减少。这些发现表明,Egr 2/3控制PD-1(高)MP CD 4 T细胞的炎症反应,并维持其适应性免疫适应性。
The transcription factors Egr2 and 3 are essential for controlling inflammatory autoimmune responses of memory phenotype (MP) CD4 T cells. However, the mechanism is still unclear. We have now found that the Egr2(+) subset (PD-1(high) MP) of MP CD4 T cells expresses high levels of checkpoint molecules (PD-1 and Lag3) and also markers of effector T cells (CXCR3 and ICAM-1). Egr2/3 are not required for PD-1(high) MP CD4 cell development but mediate a unique transcriptional programme that effectively controls their inflammatory responses, while promoting homeostatic proliferation and adaptive responses. Egr2 negative PD-1(high) MP CD4 T cells are impaired in homeostatic proliferation and adaptive responses against viral infection but display inflammatory responses to innate stimulation such as IL-12. PD-1(high) MP CD4 T cells have recently been implicated in rheumatoid arthritis pathogenesis, and we have now found that Egr2 expression is reduced in PD-1(high) MP CD4 T cells from patients with active rheumatoid arthritis compared with healthy controls. These findings demonstrate that Egr2/3 control the inflammatory responses of PD-1(high) MP CD4 T cells and maintain their adaptive immune fitness.